EcoDrugPlus

Carbonic Anhydrase 7-Like

Ensembl ID : ENSNBRG00000017367
Gene Symbol: LOC102793798
3 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSNBRG00000002978
Gene Symbol: CA4C
1 Cross references
79 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSNBRG00000003555
Gene Symbol: CA14
1 Cross references
210 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSNBRG00000002690
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase I Isoform Epsilon-Like

Ensembl ID : ENSNBRG00000005199
Gene Symbol: LOC102784880
3 Cross references
196 Possible Orthologues:

Caspase-9-Like

Ensembl ID : ENSNBRG00000022592
Gene Symbol: LOC102781823
3 Cross references
202 Possible Orthologues:

Catechol O-Methyltransferase-Like

Ensembl ID : ENSNBRG00000023483
Gene Symbol: LOC102777704
3 Cross references
215 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSNBRG00000013888
Gene Symbol: CTSS
4 Cross references
227 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSNBRG00000013767
Gene Symbol: CTSS
4 Cross references
229 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSNBRG00000013925
Gene Symbol: LOC102793340
2 Cross references
183 Possible Orthologues:

Cell Division Cycle 7-Related Protein Kinase-Like

Ensembl ID : ENSNBRG00000002849
Gene Symbol: LOC102782901
3 Cross references
207 Possible Orthologues:

Ceramide Glucosyltransferase-Like

Ensembl ID : ENSNBRG00000005486
Gene Symbol: LOC102790708
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).